A distinct SWOT portrait of Deleum Berhad.

Summary

Deleum Berhad (Deleum), formerly Deleum Sdn Bhd, is an oil and gas company that offers oilfield consulting services. The company operates through its business divisions such as power and machinery, oilfield services and maintenance, and integrated corrosion solutions. Its oilfield services and maintenance business includes a provision of wire-line equipment and services, integrated wellhead maintenance, provision of oilfield chemicals and technical services. Deleums power and machinery business comprise the provision of gas turbine packages, a supply of gas turbine parts, maintenance and installation of valves and flow regulators, and others. The company also provides repair and overhaul of motors generators, transformers, and pumps. It has operations throughout Malaysia. Deleum is headquartered in Kuala Lumpur, Malaysia.

DELEUM BERHAD (DELEUM)

Deleum Berhad Key Recent Developments

Feb 26,2018: Deleum Announces Quarterly Report On Consolidated Results For Financial Period Ended 31 Dec 2017

This comprehensive SWOT profile of Deleum Berhad provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers, and competitors better.

This company report forms part of GlobalDatas Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, GlobalDatas highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Deleum Berhad including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including

– Business description A detailed description of the company’s operations and business divisions.
– Corporate strategy Analysts summarization of the company’s business strategy.
– SWOT Analysis A detailed analysis of the company’s strengths, weakness, opportunities, and threats.
– Company history Progression of key events associated with the company.
– Major products and services A list of major products, services, and brands of the company.
– Key competitors A list of key competitors to the company.
– Key employees A list of the key executives of the company.
– Executive biographies A brief summary of the executive’s employment history.
– Key operational heads A list of personnel heading key departments/functions.
– Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
– Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
– Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
– The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
– The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
– Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
– Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
– Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Related Reports:

Deleum Berhad Company Profile – Business Operations, Strategies, SWOT Analysis and Financial Report

Deleum Berhad Strategic Analysis Review- Deleum Berhad SWOT, Outlook, Operations and Financial Profile

Deleum Berhad Company Profile – Business Operations, Strategies, SWOT Analysis and Financial Report

Deleum Berhad Strategic Analysis Review- Deleum Berhad SWOT, Outlook, Operations and Financial Profile

Contact Details:

Aarkstore Enterprise

Phone: +91 – 22 2756 4963

24/7 Online Support: +91 9987295242

Email: enquiry@aarkstore.com

Our website: https://www.aarkstore.com

Our blog: https://www.aarkstore.com/blog

Aarkstore – The Market for Stem Cell Biobanking and Storage – Size, Segments, and Trends

Summary

Purpose of Report: The purpose of this global strategic report is to prepare executives, company management, and industry investors with the data and knowledge necessary to make informed, educated decisions about commercial opportunities within the stem cell biobanking market.

This global strategic report is produced for:

• Executives of Industrial-Scale Biobanks
• Management of Stem Cell Product Companies
• Management of Stem Cell Therapy Companies
• Biobanking Industry Investors

It is designed to increase your efficiency and effectiveness in:

1. Effectively pricing stem cell biobanking services
2. Increasing revenue from stem cell biobanking services
3. Identifying new or adjunct stem cell biobanking services to offer
4. Identifying current market leaders within the stem cell biobanking market
5. Characterizing the competitive environment for the stem cell biobanking market
6. Identifying threats and opportunities within the stem cell biobanking market
7. Acquiring greater market within the stem cell biobanking market
8. Making intelligent investment decisions within the stem cell biobanking market

OVERVIEW

Stem cells are primitive cells found in all multi-cellular organisms that are characterized by self-renewal and the capacity to differentiate into mature cell types. Stem cells are still a relatively new discovery, as the first mouse embryonic stem cells were derived from embryos in 1981, but it was not until 1995 that the first culturing of embryonic stem cells from non-human primates occurred. Induced pluripotent stem cells were not produced until 2006. As a result of these discoveries, stem cells can now be derived at various points during the life cycles.

The following are stages during which stem cells can be derived:

• Embryonic stem cells, derived from blastocysts
• Fetal stem cells, obtained from fetuses
• Post-natal stem cells derived from newborn tissues, including cord blood stem cells from umbilical tissue
• Adult stem cells found in adult tissues, including hematopoietic stem cells, mesenchymal stem cells, and neural stem cells
• Induced pluripotent stem cells, reprogrammed from adult cells
• Cancer stem cells, which give rise to clonal populations of cells that form tumors or disperse in the body
• And more

Forces Driving the Stem Cell Biobanking Market

Stem cell research and experimentation is largely driven by the unique ability of stem cells to divide and replicate repeatedly. In addition, their “unspecialized” nature allows them to differentiate into a wide variety of specialized cell types. In a developing embryo, stem cells can differentiate into all of the specialized embryonic tissues. In adult organisms, stem and progenitor cells act as a repair system for the body, replenishing specialized cells.

Therefore, the possibilities arising from these characteristics have resulted in great commercial interest, with potential applications ranging from the use of stem cells in reversal and treatment of disease, to targeted cell therapy, tissue regeneration, pharmacological testing on cell-specific tissues, and more. Huntington’s disease, Parkinson’s disease, and spinal cord injuries are examples of conditions for which clinical applications involving stem cells could offer benefits in halting or even reversing adverse effects.
However, to have stem cells easily accessible for research purposes and clinical applications requires them to be preserved in stable, temperature controlled conditions. For this reason, a substantial market has evolved for the biobanking of tissues containing stem cell populations and the storage of stem cells themselves.

Stem Cell Biobanking Market

Stem cell biobanking is the cryogenic storage of stem cells, or biological samples containing stem cells, for later use. The market for these services is known as the “Stem Cell Biobanking Market.” Because stem cell biobanking often involves the long-term storage of stem cell samples, the market is sometimes is also known as the “Stem Cell Storage Market.” For purposes of this analysis, these two terms are considered to be synonymous. A definition of this market is provided below.

Stem Cell Biobanking Market:

The stem cell biobanking market is defined as the total annual revenue derived from the storage of:

1. Stem cell lines and their derivatives
2. All biological samples that were collected specifically because they contain stem cell populations (e.g. cord blood, adipose tissue, and more)

This report aims to understand and characterize the competitive environment for the stem cell biobanking market. As such, the research is focused on identifying leading participants in the stem cell storage market, distinguishing their business model, and exploring their relative market share.
Currently, the four leading providers of biobanking services are: Fisher Bioservices, Biostorage Technologies, EPL Archives, and Precision Bioservices. All four companies store millions of biological samples (15 million by Precision Bioservices, up to 170 million by Fisher Bioservices) and provide a diverse set of biobanking services. All but Precision Biosciences are multi-national companies with both U.S. and European operations. Because each company has large market share within the stem cell biobanking market, they are explored in detail within this report.

However, there are also companies specializing exclusively in stem cell storage. In one landmark event, Cellular Dynamics International (CDI) and the Coriell Institute for Medical Research announced receiving multi-million dollar grants from the California Institute for Regenerative Medicine (CIRM) for the creation of induced pluripotent stem cell (iPSC) lines from 3,000 healthy and diseased donors. CIRM awarded CDI $16 million to create three iPSC lines for each of 3,000 healthy and diseased donors and awarded the Coriell Institute $10 million to set up and biobank the iPSC lines. The result will be thecreation of the world’s largest human iPSC bank, an incredible feat.

This iPSC biobank is one example of the expanding market for stem cell biobanking services. Because the goal of stem cell biobanking is to create a repository of stem cell specimens – including source tissue from which stem cells can be derived, differentiated cell types produced, and disease-specific cell lines created – large-scale stem cell biobanks provide researchers with the opportunity to investigate a diverse range of conditions using stem cells derived from both healthy and diseased donors. Importantly, biobanks can greatly expand the capacity for global research and collaboration.

Key report findings include:

• Current Size of the Stem Cell Biobanking Market
• Trailing 5-Year Market Size Data (2011-2015)
• 5-year Market Size Projections (2016-2020)
• Market Segmentation
• Market Share by Segment
• Key Industry Leaders
• Detailed Competitive Environment Analysis
• Analysis of Stem Cell Storage Applications (End-Uses)
• Number of Stem Cell Samples Banked, by Industry Leader
• Identification of Opportunities within the Stem Cell Biobanking Market
• And Much More

Competing within the stem cell biobanking market can involve complicated and confusing decisions, but it doesn’t need to. Claim this global strategic report to quickly understand current and future trends within the stem cell biobanking marketplace, identify opportunities by market segment, and derive more revenue from your stem cell biobanking products and services.

Order full Report with TOC and Sample page visit:

http://www.aarkstore.com/healthcare/118592/the-market-for-stem-cell-biobanking-and-storage-size-segments-and-trends

Related Market Research reports: Healthcare Market Research Reports

About Aarkstore Enterprise

Aarkstore Enterprise is a leading provider of business and financial information and solutions worldwide. We specialize in providing online market business information on market research reports, books, magazines, conference at competitive prices, and strive to provide excellent and innovative service to our customers.

Contact Details:

Aarkstore Enterprise
Phone: +91 9987295242 / 022-27564953
Email: enquiry@aarkstore.com
Our Website: http://www.aarkstore.com
Our Blog : http://www.aarkstore.com/blog/
Latest News : http://www.aarkstore.com/news
Facebook: https://www.facebook.com/aarkstoredotcom

Aarkstore – Kansas City Deaerator Company – Strategic SWOT Analysis Review

Summary

“Kansas City Deaerator Company – Strategic SWOT Analysis Review” provides a comprehensive insight into the companys history, corporate strategy, business structure and operations.

The Market Research Report contains a detailed SWOT analysis, information on the companys key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

– Business description A detailed description of the companys operations and business divisions.
– Corporate strategy GlobalDatas summarization of the companys business strategy.
– SWOT analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
– Company history Progression of key events associated with the company.
– Major products and services A list of major products, services and brands of the company.
– Key competitors A list of key competitors to the company.
– Key employees A list of the key executives of the company.
– Executive biographies A brief summary of the executives employment history.
– Key operational heads A list of personnel heading key departments/functions.
– Important locations and subsidiaries A list of key locations and subsidiaries of the company, including contact details.

Highlights

Kansas City Deaerator Company (KCD) is a manufacturer and supplier of deaerators to the power and industrial sectors The company offers products such as vertical spray deaerator, horizontal spray deaerator, tank car tray deaerator, bolted double shell tray deaerator (bolted vertical heater with horizontal storage) and horizontal heater tray deaerator (horizontal heater welded to horizontal storage). It provides accessories such as gauge glass, level switches, thermometer, relief valve, control valves, overflow valves and others. The company also provides ancillary equipment and pump package system. KCD engages in research and development of new and enhanced technology in the field of deaerators. KCD is headquartered in Overland Park, Kansas, the US.

Reasons to Buy

– Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
– Identify potential customers and suppliers with this reports analysis of the companys business structure, operations, major products and services and business strategy.
– Understand and respond to your competitors business structure and strategies with GlobalDatas detailed SWOT analysis. In this, the companys core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
– Examine potential investment and acquisition targets with this reports detailed insight into the companys strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Order full Report with TOC and Sample page visit:

http://www.aarkstore.com/nuclear-energy/104233/kansas-city-deaerator-company-strategic-swot-analysis-review

Related Market Research reports: Nuclear Energy Market Research Reports

About Aarkstore Enterprise

Contact Details:

Aarkstore – NFM Technologies – Strategic SWOT Analysis Review

Summary

“NFM Technologies – Strategic SWOT Analysis Review” provides a comprehensive insight into the companys history, corporate strategy, business structure and operations.

The Market Research Report contains a detailed SWOT analysis, information on the companys key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

– Business description A detailed description of the companys operations and business divisions.
– Corporate strategy GlobalDatas summarization of the companys business strategy.
– SWOT analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
– Company history Progression of key events associated with the company.
– Major products and services A list of major products, services and brands of the company.
– Key competitors A list of key competitors to the company.
– Key employees A list of the key executives of the company.
– Executive biographies A brief summary of the executives employment history.
– Key operational heads A list of personnel heading key departments/functions.
– Important locations and subsidiaries A list of key locations and subsidiaries of the company, including contact details.

Highlights

NFM Technologies (NFM) is a mechanical engineering company. NFM designs and manufactures high-tech heavy mechanical equipment for various markets such as oil and gas; nuclear power; underground work; major structures market and transport industries. The company specializes in designing and manufacturing tunnel boring machines and special equipments. Its product portfolio includes hard rock machines, soft ground machines, dual-mode machines handling / transhipment equipment and systems, production tools and civil engineering equipment among others. NFM also provides services such as technical assistance, inspection and replacements of cutting tools, and maintenance of the machines. The company’s operations are spread across various countries in Europe and Asia. It is a subsidiary of Northern Heavy Industries Group Co., Ltd. NFM is headquartered in Lyon, France.

Reasons to Buy

Note: Some sections may be missing if data is unavailable for the company.

Order full Report with TOC and Sample page visit:

http://www.aarkstore.com/nuclear-energy/104232/nfm-technologies-strategic-swot-analysis-review

Related Market Research reports: Nuclear Energy Market Research Reports

About Aarkstore Enterprise

Contact Details:

Aarkstore – Emerson Process Management – Strategic SWOT Analysis Review

Summary

“Emerson Process Management – Strategic SWOT Analysis Review” provides a comprehensive insight into the companys history, corporate strategy, business structure and operations.

The Market Research Report contains a detailed SWOT analysis, information on the companys key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

Highlights

Emerson Process Management (EPM) is engaged in providing businesses engineering, consulting, project management and maintenance services to automate their production, distribution and processing in the oil and gas, refining, pulp and paper, chemical, power, water and wastewater treatment, food and beverage, life sciences, metals and mining industries. It is the subsidiary of Fisher-Rosemount Systems, Inc., which is a part of Emerson Electric Co. EPM offers products such as valves, regulators, control element systems, software, transmitters, radars and controllers. Its key services are asset optimization services, educational services, instrument and valve services, modernization and migration services, process automation services, sureservice system support, smart wireless services, and after-project support. Its brand portfolio includes PlantWeb, Syncade, DeltaV, Fisher, Micro Motion, Rosemount, Daniel, Ovation, and AMS Suite. EPM carries out the development and manufacture of industrial automation and control systems. EPM is headquartered in Minnesota, the US.

The company focuses on improving its existing products and innovating new products in its core business areas. Thus, the company invests in mergers, acquisitions and research and development activities. In line with this objective the company opened a new research and development facility within the Asia Flow Technology Center in Nanjing which focuses on developing flow metering and measurement technologies which will help process manufacturers tackle their engineering challenges. It also opened a flow loop facility for Roxar technologies in Stavanger, Norway.

Emerson Process Management Key Recent Developments

Dec 12, 2013: Emerson introduces integrated prediction and protection system for hydroelectric turbines
Nov 14, 2013: Kenya Power to construct KES247m substation at JKUAT
Nov 13, 2013: Emerson Awarded $11 Million Contract to Automate Two 1,050-Megawatt Ultra-Supercritical Units at South Korea Power Plant
Nov 04, 2013: Emerson introduces electro-pneumatic transducer to help oil and gas industry meet EPA emission requirements
Sep 03, 2013: Emerson Wins $17 Million Contract to Automate Premier Oil Platform on UK Continental Shelf

Reasons to Buy

Note: Some sections may be missing if data is unavailable for the company.

Order full Report with TOC and Sample page visit:

http://www.aarkstore.com/nuclear-energy/103829/emerson-process-management-strategic-swot-analysis-review

Related Market Research reports: Nuclear Energy Market Research Reports

About Aarkstore Enterprise

Contact Details:

Aarkstore – Nuvia Limited – Strategic SWOT Analysis Review

Summary

“Nuvia Limited – Strategic SWOT Analysis Review” provides a comprehensive insight into the companys history, corporate strategy, business structure and operations.

The Market Research Report contains a detailed SWOT analysis, information on the companys key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

Highlights

Nuvia Limited (Nuvia), formerly NUKEM Limited is one of the leading international engineering, project management and services provider. The companys product portfolio includes ModuCon for HVAC and containment; Modcube for waste management; HiRAM, GEM and Grounghog for radiation protection; and nuclear measurement. Its services include project management, engineering procure construction, operational services, radiation protection services, consulting, procurement, programme management and training. Nuvia offers its services across various sectors including nuclear; defence; oil and gas; and science and research to commercial clients, government bodies and international agencies. It is a subsidiary of Soletanche Freyssinet. Nuvia is headquartered at Warrington, Cheshire, the UK.

Reasons to Buy

Note: Some sections may be missing if data is unavailable for the company.

Order full Report with TOC and Sample page visit:

http://www.aarkstore.com/nuclear-energy/104234/nuvia-limited-strategic-swot-analysis-review

Related Market Research reports: Nuclear Energy Market Research Reports

About Aarkstore Enterprise

Contact Details:

Aarkstore – Frontier Pharma: Alzheimers Disease – Identifying and Commercializing First-in-Class Innovation

Summary

Large and Innovative Pipeline

The active Alzheimer’s Disease (AD) pipeline is populated with 583 products, with a highly diverse range of molecular targets. GBI Research analysis revealed a high degree of innovation in this indication, with 46% of the pipeline being first-in-class products, acting on over 40 first-in-class molecular targets. In addition, the pipeline is characterized by the strong presence of therapies that target multiple components implicated in the amyloid cascade, several molecular targets of which are known to trigger familial AD. Given that the currently approved therapies for AD are limited to acetylcholinesterase inhibitors and glutamate receptor antagonists, the pipeline offers a broad range of treatment options that may possess disease-modifying properties. However, evaluation of the Preclinical and clinical evidence for their therapeutic potential reveals that the novelty of the molecular target is not sufficient to effectively reduce the rate of AD progression in human patients.

Disease-Modifying Therapies Show Promise in Early-Stage Development

Programs undergoing Preclinical development exhibit diverse disease-modifying mechanisms of action, and many represent strong alternatives to targets with a direct role in the amyloid and tau processes due to their roles in promoting neuronal survival and plasticity, a process critical to memory and cognition. Brain-Derived Neurotrophic Factor (BDNF) and Nerve Growth Factor (NGF) are considered promising targets in AD, primarily due to their potency in exhibiting significant neuroprotective effects in Preclinical studies. Members of the caspase-mediated apoptotic cascade also show therapeutic potential, as early investigations have revealed an ability to modulate molecular mechanisms underlying synaptic plasticity in animal models, which translates into amelioration of behavioral deficits. Thus, growing insights into disease-causing processes in AD are being translated into a growing population of innovative therapeutic targets, as reflected in the highly innovative pipeline.

The merits of novel molecular targets depend largely on the body of Preclinical evidence underpinning their relevance to AD pathology. Many endpoints in Preclinical investigations focus on amelioration of amyloid burden and tau pathology, as well as cognitive performance in animal model systems. Based on these assessment criteria, it appears that programs targeting the amyloid cascade, tau pathology, and the promotion of neuronal survival and plasticity all demonstrate promising efficacy profiles. Other first-in-class targets that are less directly aligned to these three processes may not be able to confer disease-modifying properties and therefore lack clinical and commercial potential.

Active Deals Landscape with Numerous Investment Opportunities

The AD deals landscape has been highly active over the past eight years, with 83 licensing agreements and 103 co-development deals. Overall, non-first-in-class programs tend to have lower valuations than first-in-class programs across all stages of drug development, which highlights their commercial attractiveness, even in early-stage development. Although first-in-class programs are associated with greater risk, they have more potential to revolutionize or improve therapeutic options, meaning that identifying promising first-in-class compounds early in development offers the greatest potential commercial benefit to pharmaceutical companies.

With 153 first-in-class products that are currently in development having not yet been involved in a licensing or co-development deal, there are numerous opportunities for in-licensing or co-development in this indication.

Scope

The report covers and includes –
– A brief introduction to AD, including symptoms, pathophysiology, and overview of pharmacotherapy and treatment algorithms
– The changing molecular target landscape between market and pipeline and particular focal points of innovation in the pipeline
– A comprehensive review of the pipeline for first-in-class therapies, analyzed on the basis of stage of development, molecule type and molecular target
– Identification and assessment of first-in-class molecular targets with a particular focus on early-stage programs for which clinical utility has yet to be evaluated, as well as literature reviews of novel molecular targets
– Assessment of the licensing and co-development deal landscape for AD therapies and benchmarking of deals involving first-in-class versus non-first-in-class-products

Reasons to buy

The report will assist business development and enable marketing executives to strategize their product launches, by allowing them to –
– Understand the focal shifts in molecular targets in the AD pipeline
– Understand the distribution of pipeline programs by phase of development, molecule type and molecular target
– Access a scientific and clinical analysis of first-in-class developmental programs for AD, benchmarked against non-first-in-class targets
– Access a list of the first-in-class therapies potentially open to deal-making opportunities

Browse complete Report on:

http://www.aarkstore.com/pharmaceuticals-healthcare/105777/frontier-pharma-alzheimers-disease-identifying-and-commercializing-first-in-class-innovation

Related Market Research reports: Pharmaceuticals & Healthcare Market Research Reports

About Aarkstore Enterprise

Contact Details:

Aarkstore – MediPoint: Nuclear Imaging – PET and SPECT Equipment – Global Analysis and Market Forecasts

Summary

This Market Research Report “MediPoint: Nuclear Imaging – PET and SPECT Equipment – Global Analysis and Market Forecasts” examines how new technologies can emerge in the face of economic pressures that may affect the demand for nuclear imaging, and how healthcare reforms are impacting nuclear medicine.

The advent of hybrid imaging has enabled PET/CT imaging to undergo explosive growth. However, this has been at the cost of an increased demand on struggling healthcare budgets

PET and SPECT imaging are well established techniques within nuclear imaging, and are the main focus of this report

PET imaging uses Positron Emitting radioactive tracers with a short half life, to image metabolically active organs

PET combined with CT allows precise anatomical imaging of the body, identifying diseased areas depending upon the tracer used

PET/CT is most often used for cancer diagnosis

PET/MRI is a new technique that was introduced to reduce patient exposure to radiation

PET only systems are now generally considered obsolete, due to the superior imaging quality of PET/CT

SPECT imaging uses Gamma Emitting radioactive tracers with a longer half life, to image molecular processes in the body

SPECT and SPECT/CT are most often used in cardiology studies

The SPECT and SPECT/CT market is a bigger market than the PET, PET/CT and PET/MRI, because the instruments have been in longer use, are cheaper, and have become the common technique for a wide range of indications

Physicians believe more and more SPECT procedures will be replaced by PET procedures

New developments in hybrid nuclear imaging promise to further increase the utility of hybrid nuclear imaging, while significantly improving patient cost-savings and safety, through reduced need for repeat examinations.

This report focuses on the current and future industry trends within the nuclear medicine market, as well as discussing the promising pipeline products, and assessing the competitive landscape.

Highlights

Key Questions Answered

– What is the current and future nuclear imaging market outlook in the developed and emerging markets? What trends are affecting the global market for both SPECT and PET imaging systems?
– Which are the key, high growth markets that manufacturers should seek to expand into? What are the types of products that are most likely to succeed?
– How many Nuclear Imaging Procedures are carried out in each of the 10 Major Markets? What does this imply for instrument adoption rates?
– What are the major unmet needs in nuclear imaging? In which areas can manufacturers help meet that need?
– What factors most influence a physician or hospital in the purchase of new nuclear imaging equipment? How much can a physician influence purchasing decisions?
– How will reimbursement changes will affect nuclear imaging. How has the Affordable Care Act affected nuclear imaging? How will it affect it in the future?
– How well are new paradigms in nuclear imaging perceived? What motivates companies to develop a new nuclear imaging modality; physician demand or legislative requirement?

Key Findings

– Nuclear Imaging is a moderately growing market, with a CAGR of 3.3% for the period to 2020
– PET/CT, SPECT, SPECT/CT and Scinitgraphy are the major techniques in nuclear imaging
– US dominates the world market for nuclear imaging equipment
– US will see lowest growth in nuclear imaging equipment thanks to reimbursement pressures
– Japan and China will present the greatest opportunities for growth, with respective market shares increasing by 75% and almost 100% during the forecasted period
– BIC nations will experience the highest growth rates in nuclear imaging equipment during the forecast period
– Non-PET nuclear imaging procedures in the developed markets (US, 5EU, Japan) likely overall to fall during forecast period, as a result of increasing reimbursement pressures and new technologies
– PET imaging procedures in all markets likely to increase during the forecast period, despite reimbursement pressures, due to increased number of indications

Scope

– Overview of Nuclear Imaging, including core technologies, estimated procedure trends and disease overview.
– Current and Future Players Companies involved in the space with portfolio assessment and SWOT analysis.
– Pipeline analysis: Comprehensive data split across different stages of development, emerging trends and nuclear imaging devices in development
– Annualized total nuclear imaging equipment market revenue for SPECT, SPECT/CT, PET, PET/CT and PET/MRI, and procedure data for 2012-2013, and forecast for seven years to 2020
– Other Key topics covered include identification of unmet needs, implications for the nuclear imaging market and how they may be overcome in the near future, reimbursement and regulatory considerations, evaluating market access for each region covered in the report
– Analysis of the market opportunities in the Nuclear Imaging market, in addition to Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications

Reasons to buy

– Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline in the fields of PET/CT, PET/MRI and SPECT/CT.
– Develop business strategies by understanding the trends shaping and driving the nuclear imaging market
– Drive revenues by understanding the key trends, innovative products and technologies, and companies likely to impact the nuclear imaging market in the future
– Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the performance of various competitors
– Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage
– Track device sales in the global and country-specific nuclear imaging markets from 2012-2020
– Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships

Browse complete Report on:

http://www.aarkstore.com/general-medical-devices/84788/medipoint-nuclear-imaging-pet-and-spect-equipment-global-analysis-and-market-forecasts

Related Market Research reports: General Medical Devices Market Research Reports

About Aarkstore Enterprise

Contact Details:

Aarkstore – Global Propylene Industry On-Purpose Technologies to Gain Prominence

Summary

GlobalData, the industry analysis specialist, has released its latest research, “Global Propylene Industry – On-Purpose Technologies to Gain Prominence”. The study comes from the company’s oil and gas research group and provides market analysis of the global propylene industry, highlighting major features of the industry.

The Market Research Report gives the historic and forecast, market size, demand and production figures by region. It covers all five regions that include Asia-Pacific, Europe, North America, South America, and Middle East and Africa. The report has been built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s research team of industry experts.

The global propylene industry is witnessing a change in the feedstock scenario in various parts of the world. In North America, propylene supply from steam crackers is expected to decrease in coming years as abundant and inexpensive natural gas liquids (NGLs) feedstock form shale gas is slowly replacing heavy feedstock in steam crackers. Persistently high crude oil price is also discouraging the use of naphtha China and Europe. To cope with the changing feedstock scenario and high crude oil prices many producers are embracing on-purpose propylene technologies which produce high quantities of propylene by using alternative feedstocks such as NGLs and coal. Use of these technologies is being witnessed mostly in Asia-Pacific and North America. In Asia-Pacific, more than 50% of new capacity will come from on-purpose technologies while in North America, 100% of the new capacity will come from on-purpose technologies. With the increasing demand for propylene and uncertainty of propylene supply from stream crackers, the use of on-purpose technology will continue to increase in the future.

Scope

The report provides in-depth analysis of the demand and supply dynamics of the global propylene industry. Its scope includes –

– Historic and forecast global propylene capacity by region
– Propylene planned plants details
– Global propylene capacity by feedstock
– Capacity share of the major propylene producers in the world
– Historic and forecast propylene market size, demand and production by region
– Global propylene demand by end-use sectors
– Propylene price forecast by region
– Company profile of three largest company in the propylene industry

Reasons to buy

The report will enhance your decision-making capability by allowing you to –

– Understand the key trends and challenges in the global propylene industry
– Understand the regional propylene supply scenario
– Understand the current and likely future competitive scenario
– Identify opportunities in the global propylene industry with the help of specific insights on demand and supply dynamics
– Increase future revenues and profitability with the help of insights into future opportunities and critical success factors in the global propylene industr

Browse complete Report on:

http://www.aarkstore.com/chemicals/117603/global-propylene-industry-on-purpose-technologies-to-gain-prominence

Related Market Research reports: Chemicals Market Research Reports

About Aarkstore Enterprise

Contact Details:

Aarkstore – Gas Processing Industry Outlook in Europe, 2014

Summary

“Gas Processing Industry Outlook in Europe, 2014 – Investment Opportunities, Analysis and Forecasts of All Active and Planned Gas Processing Plants in Europe” is a comprehensive report on gas processing industry in Europe. It provides in-depth asset details of all active and planned plants in the region. Details include operator name, start year, process/conditioning methods and processing capacity. Planned plants as announced by the companies have been included in the report. The research gives information on the market shares of major gas processing companies in Europe. The report also provides profiles of three major gas processing operators in Europe.

Scope

– The report provides detailed information and analysis on gas processing plants in Europe.
– The research work includes country wise processing capacities of active and planned processing plants in the region
– Information on gas processing capacity of top five companies is provided
– Profiles of three major companies operating in the industry are also included in the report.

Reasons to buy

– The report will enhance your decision making capability in a more rapid and time sensitive manner.
– The research will allow you to identify prospective investment targets through a comprehensive update and discussion on processing plants
– Decide on market entry strategies in specific markets with the help of an up-to-date review of all gas processing plant capacities
– Benchmark yourself against major gas processing companies by leveraging on our detailed company analysis.

Browse complete Report on:

http://www.aarkstore.com/energy-power/89554/gas-processing-industry-outlook-in-europe-2014-investment-opportunities-analysis-and-forecasts

Related Market Research reports: Energy & Power Market Research Reports

About Aarkstore Enterprise

Contact Details: